In response to the national shortage of GLP-1 analogues across the NHS, we are implementing a GLP-1 optimisation project, which aims to engage with patients on this medication, to:
- Identify those with a genuine indication or need for this class of medication
- Where indicated, to ensure that patients have adequate supply of their GLP-1 analogues
- Evaluate patients for which GLP-1s may no longer be indicated, or where they could safely move to an alternative medication
- Obtain patient consent to consider stopping or changing their GLP-1 medication
- To provide significant cost-savings to the NHS
This pathway aims to gather important patient information around their diabetes management, empower patient-led care while safely addressing the national medication shortage.
